thiazoles has been researched along with fosbretabulin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anthoney, DA; Bibby, MC; Cooper, PA; Kirwan, IG; Lippert, JW; Loadman, PM; Pettit, GR; Shnyder, SD; Swaine, DJ | 1 |
| Burnett, JC; Day, BW; Gussio, R; Hamel, E; Hermone, AR; McGrath, C; Nguyen, TL; Wipf, P; Zaharevitz, DW | 1 |
| Banerjee, S; Mohammad, M; Mohammad, RM; Sarkar, FH; Wang, Z | 1 |
| Chiu, CT; Chung, TH; Jow, GM; Liao, CK; Lin, PC; Shen, CC; Wu, JC | 1 |
| Feng, LY; Li, XR; Lin, NM; Pan, JP; Wang, BM; Wang, JB; Zhang, C; Zhang, DY; Zhang, LH; Zhou, SS | 1 |
| Awuah, SG; Bio, M; Hossion, AM; Nkepang, G; Rajaputra, P; You, Y | 1 |
| Chen, L; He, L; Liu, Y; Ma, L; Nie, C; Pu, Y; Shao, M; Wang, F; Wu, W; Wu, Y; Yang, Z; Yu, K | 1 |
1 review(s) available for thiazoles and fosbretabulin
| Article | Year |
|---|---|
Efficacy of selected natural products as therapeutic agents against cancer.
Topics: Animals; Antineoplastic Agents; Biological Products; Bryostatins; Depsipeptides; Humans; Models, Biological; Molecular Structure; Oligopeptides; Stilbenes; Thiazoles | 2008 |
6 other study(ies) available for thiazoles and fosbretabulin
| Article | Year |
|---|---|
Comparative preclinical pharmacokinetic and metabolic studies of the combretastatin prodrugs combretastatin A4 phosphate and A1 phosphate.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Area Under Curve; Bibenzyls; Calibration; Cell Line, Tumor; Chromatography; Chromatography, High Pressure Liquid; Coloring Agents; Female; Humans; Inhibitory Concentration 50; Mass Spectrometry; Mice; Models, Chemical; Phosphorylation; Prodrugs; Stilbenes; Tetrazolium Salts; Thiazoles; Time Factors | 2004 |
A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach.
Topics: 2-Methoxyestradiol; 4-Butyrolactone; Aminophenols; Binding Sites; Chalcone; Colchicine; Cyclopropanes; Estradiol; Indans; Lignans; Models, Molecular; Molecular Structure; Nocodazole; Podophyllotoxin; Protein Binding; Stilbenes; Structure-Activity Relationship; Sulfonamides; Thiazoles; Tubulin; Tubulin Modulators | 2005 |
HYS-32, a novel analogue of combretastatin A-4, enhances connexin43 expression and gap junction intercellular communication in rat astrocytes.
Topics: 4-Butyrolactone; Animals; Animals, Newborn; Antineoplastic Agents, Phytogenic; Astrocytes; Blotting, Western; Cell Communication; Cells, Cultured; Coloring Agents; Connexin 43; Enzyme Inhibitors; Female; Gap Junctions; Image Processing, Computer-Assisted; Male; Microscopy, Fluorescence; Naphthalenes; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Signal Transduction; Stilbenes; Tetrazolium Salts; Thiazoles | 2013 |
Enhanced antitumor activity by the combination of dasatinib and combretastatin A-4 in vitro and in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspase 3; Cell Line, Tumor; Dasatinib; DNA Damage; Drug Synergism; Humans; Mice; Mice, Nude; Mitochondria; Myeloid Cell Leukemia Sequence 1 Protein; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Pyrimidines; Stilbenes; Thiazoles; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
Site-specific and far-red-light-activatable prodrug of combretastatin A-4 using photo-unclick chemistry.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Chemistry, Pharmaceutical; Coloring Agents; Cross-Linking Reagents; Darkness; Dermatitis, Phototoxic; Fluorescent Dyes; Light; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Porphyrins; Prodrugs; Stilbenes; Structure-Activity Relationship; Tetrazolium Salts; Thiazoles; Tubulin | 2013 |
Synthesis and biological evaluation of diarylthiazole derivatives as antimitotic and antivascular agents with potent antitumor activity.
Topics: Angiogenesis Inhibitors; Animals; Antimitotic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Cell Line, Tumor; Cell Movement; Colchicine; Colonic Neoplasms; Drug Resistance, Neoplasm; Female; G2 Phase Cell Cycle Checkpoints; Gene Expression; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Inbred BALB C; Protein Binding; Stilbenes; Structure-Activity Relationship; Thiazoles; Tubulin Modulators; Xenograft Model Antitumor Assays | 2015 |